Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Johnson & Johnson

JNJ
Current price
144.77 USD -0.23 USD (-0.16%)
Last closed 144.45 USD
Sector Healthcare
Industry Drug Manufacturers - General
Exchange NYSE
Capitalization 348 092 694 528 USD
Yield for 12 month -10.09 %
1Y
3Y
5Y
10Y
15Y
JNJ
21.11.2021 - 28.11.2021

Johnson & Johnson, together with its subsidiaries, researches, develops, manufactures, and sells various products in the healthcare field worldwide. The company's Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizophrenia; oncology, such as prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; cardiovascular and metabolism, including thrombosis, diabetes, and macular degeneration; and pulmonary hypertension comprising pulmonary arterial hypertension through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. Its MedTech segment provides Interventional Solutions, including electrophysiology products to treat heart rhythm disorders; the heart recovery portfolio, which includes technologies to treat severe coronary artery disease requiring high-risk PCI or AMI cardiogenic shock; and neurovascular care that treats hemorrhagic and ischemic stroke. this segment also offers an orthopaedics portfolio that includes products and enabling technologies that support hips, knees, trauma, spine, sports, and other; surgery portfolios comprising advanced and general surgery technologies, as well as solutions for breast aesthetics, ear, nose, and throat procedures; contact lenses under the ACUVUE Brand; and TECNIS intraocular lenses for cataract surgery. It distributes its products to wholesalers, hospitals, and retailers, as well as physicians, nurses, hospitals, eye care professionals, and clinics. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey. Address: One Johnson & Johnson Plaza, New Brunswick, NJ, United States, 08933

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

176.17 USD

P/E ratio

27.7788

Dividend Yield

3.23 %

Current Year

+85 152 000 000 USD

Last Year

+94 943 000 000 USD

Current Quarter

+21 391 000 000 USD

Last Quarter

+21 345 000 000 USD

Current Year

+58 413 000 000 USD

Last Year

+63 854 000 000 USD

Current Quarter

+14 395 000 000 USD

Last Quarter

+14 841 000 000 USD

Key Figures JNJ

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 30 766 999 552 USD
Operating Margin TTM 22.11 %
PE Ratio 27.7788
Return On Assets TTM 8.33 %
PEG Ratio 0.8879
Return On Equity TTM 18.31 %
Wall Street Target Price 176.17 USD
Revenue TTM 85 159 002 112 USD
Book Value 28.57 USD
Revenue Per Share TTM 33.61 USD
Dividend Share 4.7 USD
Quarterly Revenue Growth YOY 7.3 %
Dividend Yield 3.23 %
Gross Profit TTM 63 954 000 000 USD
Earnings Share 5.2 USD
Diluted Eps TTM 5.2 USD
Most Recent Quarter IV 2023
Quarterly Earnings Growth YOY 10.6 %
Profit Margin 41.28 %

Dividend Analytics JNJ

King - 50 or more consecutive years of dividend increases

Dividend growth over 5 years

33 %

Continuous growth

52 years

Payout Ratio 5 years average

58 %

Dividend History JNJ

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate 4.76
Ex Dividend Date 16.02.2024
Forward Annual Dividend Yield 3.23 %
Last Split Factor 2:1
Payout Ratio 45.64 %
Last Split Date 13.06.2001
Dividend Date 05.03.2024

Stock Valuation JNJ

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 27.7788
Forward PE 13.8504
Enterprise Value Revenue 4.2497
Price Sales TTM 4.1744
Enterprise Value EBITDA 15.5187
Price Book MRQ 5.169

Financials JNJ

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators JNJ

For 52 weeks

143.39 USD 173.31 USD
50 Day MA 156.78 USD
Shares Short Prior Month 14 850 157
200 Day MA 158.74 USD
Short Ratio 2.24
Shares Short 15 943 156
Short Percent 0.66 %

Dynamics of changes in the value of assets

Stocks


MSFT

MSFT

411.84 USD Microsoft Corporation -5.76 (-1.38%)
Detailed analytics

ETF funds


M

MDAXEX

208.40 CHF iShares MDAX UCITS ETF (DE) -12.16 (-5.06%)
Detailed analytics

Metals


Gold

2205.6 USD Gold +35.66 (+1.64%)
Detailed analytics